Literature DB >> 19036766

Serum uric acid and cognitive function and dementia.

S M Euser1, A Hofman, R G J Westendorp, Monique M B Breteler.   

Abstract

Uric acid is a risk factor of cardiovascular disease, as well as a major natural antioxidant, prohibiting the occurrence of cellular damage. The relation between uric acid and cognitive decline, in which both vascular mechanisms and oxidative stress are thought to play a role, is unknown. Therefore we assessed the relation between serum uric acid levels and the risk of subsequent dementia in a prospective population-based cohort study among 4618 participants aged 55 years and over. Additionally, we investigated the relation between serum uric acid and cognitive function later in life (on average 11.1 years later) in a subsample of 1724 participants who remained free of dementia during follow-up. All analyses were adjusted for age, sex and cardiovascular risk factors. Our data showed that only after correcting for several cardiovascular risk factors, higher serum uric acid levels were associated with a decreased risk of dementia (HR, adjusted for age, sex and cardiovascular risk factors, 0.89 [95% confidence interval (CI) 0.80-0.99] per standard deviation (SD) increase in uric acid). In participants who remained free of dementia, higher serum uric acid levels at baseline were associated with better cognitive function later in life, for all cognitive domains that were assessed [adjusted difference in Z-score (95% CI) per SD increase in uric acid 0.04 (0.00-0.07) for global cognitive function; 0.02 (-0.02 to 0.06) for executive function; and 0.06 (0.02-0.11) for memory function], but again only after correcting for cardiovascular risk factors. We conclude that notwithstanding the associated increased risk of cardiovascular disease, higher levels of uric acid are associated with a decreased risk of dementia and better cognitive function later in life.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19036766     DOI: 10.1093/brain/awn316

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  80 in total

1.  Crowdsourced analysis of clinical trial data to predict amyotrophic lateral sclerosis progression.

Authors:  Robert Küffner; Neta Zach; Raquel Norel; Johann Hawe; David Schoenfeld; Liuxia Wang; Guang Li; Lilly Fang; Lester Mackey; Orla Hardiman; Merit Cudkowicz; Alexander Sherman; Gokhan Ertaylan; Moritz Grosse-Wentrup; Torsten Hothorn; Jules van Ligtenberg; Jakob H Macke; Timm Meyer; Bernhard Schölkopf; Linh Tran; Rubio Vaughan; Gustavo Stolovitzky; Melanie L Leitner
Journal:  Nat Biotechnol       Date:  2014-11-02       Impact factor: 54.908

Review 2.  Gout, hyperuricemia, and Parkinson's disease: a protective effect?

Authors:  Alvaro Alonso; Kelly A Sovell
Journal:  Curr Rheumatol Rep       Date:  2010-04       Impact factor: 4.592

3.  Serum uric acid and impaired cognitive function in a cohort of healthy young elderly: data from the Brisighella Study.

Authors:  Arrigo Francesco Giuseppe Cicero; Giovambattista Desideri; Giulia Grossi; Riccardo Urso; Martina Rosticci; Sergio D'Addato; Claudio Borghi
Journal:  Intern Emerg Med       Date:  2014-07-02       Impact factor: 3.397

4.  Cause-Specific Mortality in Gout: Novel Findings of Elevated Risk of Non-Cardiovascular-Related Deaths.

Authors:  Ana Beatriz Vargas-Santos; Tuhina Neogi; Geraldo da Rocha Castelar-Pinheiro; Meliha C Kapetanovic; Aleksandra Turkiewicz
Journal:  Arthritis Rheumatol       Date:  2019-09-25       Impact factor: 10.995

5.  Association of amine biomarkers with incident dementia and Alzheimer's disease in the Framingham Study.

Authors:  Vincent Chouraki; Sarah R Preis; Qiong Yang; Alexa Beiser; Shuo Li; Martin G Larson; Galit Weinstein; Thomas J Wang; Robert E Gerszten; Ramachandran S Vasan; Sudha Seshadri
Journal:  Alzheimers Dement       Date:  2017-06-08       Impact factor: 21.566

6.  Serum Uric Acid and Its Association with Longitudinal Cognitive Change Among Urban Adults.

Authors:  May A Beydoun; Jose-Atilio Canas; Gregory A Dore; Hind A Beydoun; Ola S Rostant; Marie T Fanelli-Kuczmarski; Michele K Evans; Alan B Zonderman
Journal:  J Alzheimers Dis       Date:  2016-04-21       Impact factor: 4.472

Review 7.  Insight into rheumatological cause and effect through the use of Mendelian randomization.

Authors:  Philip C Robinson; Hyon K Choi; Ron Do; Tony R Merriman
Journal:  Nat Rev Rheumatol       Date:  2016-07-14       Impact factor: 20.543

Review 8.  Targeting urate to reduce oxidative stress in Parkinson disease.

Authors:  Grace F Crotty; Alberto Ascherio; Michael A Schwarzschild
Journal:  Exp Neurol       Date:  2017-06-13       Impact factor: 5.330

9.  Assessment of serum uric acid as risk factor for tauopathies.

Authors:  Tommaso Schirinzi; Giulia Di Lazzaro; Vito Luigi Colona; Paola Imbriani; Mohammad Alwardat; Giulia Maria Sancesario; Alessandro Martorana; Antonio Pisani
Journal:  J Neural Transm (Vienna)       Date:  2017-06-15       Impact factor: 3.575

10.  Uric Acid and Neurocognitive Function in Survivors of Childhood Acute Lymphoblastic Leukemia Treated with Chemotherapy Only.

Authors:  Yin Ting Cheung; Michelle N Edelmann; Daniel A Mulrooney; Daniel M Green; Wassim Chemaitilly; Neena John; Leslie L Robison; Melissa M Hudson; Kevin R Krull
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2016-06-26       Impact factor: 4.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.